Skip to main content
FDA expands MRI labeling for LivaNova's VNS Therapy device
6/22/2017

LivaNova's Vagus Nerve Stimulation Therapy device has been granted expanded MRI labeling by the FDA. The approval allows patients using the minimally invasive device to have an appointment at any MRI center in the US and have access to over 90% of routine scans performed on patients with epilepsy.

Full Story: